Citations

Clear

4847 citation(s) found for "Yu, Eric".

Particles versus photons for the treatment of chordoma
Dutta, Sunil W. , Lehrer, Eric J. , Jha, Robin, Khan, Mohammed Latif , Sayed, Iman El , Showalter, Timothy N. , Trifiletti, Daniel M.

Mayo Clinic

Cochrane Database of Systematic Reviews | December 17, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/14651858.cd013224 Get It

Clinical Use of a Home Sleep Apnea Test: An Updated American Academy of Sleep Medicine Position Statement
Rosen, Ilene M. , Kirsch, Douglas B. , Carden, Kelly A., Malhotra, Raman K. , Ramar, Kannan , Aurora, R. Nisha , Kristo, David A., Olson, Eric J. , Rosen, Carol L. , Rowley, James A. , Shelgikar, Anita V., Martin, Jennifer L.

Mayo Clinic

Journal of Clinical Sleep Medicine | December 14, 2018 | Volume: 14 | Issue: 12 | Pages: 2075-2077

10.5664/jcsm.7540 | PMID 30518456 Get It

Practical Implementation of a Single-Night Split-Titration Protocol With BPAP-ST and AVAPS in Patients With Neuromuscular Disease
Patel, Salma , Gay, Peter C. , Olson, Eric J. , Shamoun, Fadi , Herold, Daniel L. , McNamara, Sarah, Selim, Bernardo J., Patel, Salma I, Gay, Peter, Morgenthaler, Timothy I. , Shamoun, Fadi E., Herold, Daniel, Selim, Bernardo, Kashyap, Rahul , McNamara, Sarah

Mayo Clinic

Journal of Clinical Sleep Medicine | December 14, 2018 | Volume: 14 | Issue: 12 | Pages: 2031-2035

10.5664/jcsm.7530 | PMID 30518448 Get It

A case of YY1‐associated syndromic learning disability or Gabriele‐de Vries syndrome with myasthenia gravis
Morales‐Rosado, Joel A. , Kaiwar, Charu , Smith, Benn E., Klee, Eric W. , Dhamija, Radhika , Morales-Rosado, Joel A , Dhamija, Radhika

Mayo Clinic

American Journal of Medical Genetics Part A | December 14, 2018 | Volume: 176 | Issue: 12 | Pages: 2846-2849

10.1002/ajmg.a.40626 | PMID 30549423 Get It

AbstractExome sequencing is being used increasingly to evaluate patients with intellectual disability. YY1 is a ubiquitously distributed transcription factor belonging to the GLIKruppel class of zinc finger proteins recently recognized as the causative gene in 23 patients for the Gabriele‐de Vries syndrome. We report a new case with similar features and a novel variant in YY1, in a region of the gene, which has not previously been reported. A 25 year old female was referred to clinical genetics with a diagnosis of autoimmune myasthenia gravis, facial dysmorphism and learning disability. Chromosomal microarray and gene panel test for congenital myasthenic syndrome was negative. Whole exome sequencing (WES) revealed a presumed pathogenic de novo novel, heterozygous, truncating variant in the YY1 gene, c.860_864delTTAAAA, p.Ile287Argfs*3. The Ile287 residue is conserved across species and is situated in the transcription repressor domain of the protein. This variant is novel and lies in a domain of the protein where no previously reported variants occur. The phenotypic features of our case closely match those of the reported patients. Autoimmune myasthenia gravis has not been reported in these patients and may constitute an expansion of this phenotypic spectrum or perhaps more likely a second unrelated diagnosis.
Partial Costotransversectomy and Corpectomy for Thoracic Spinal Metastatic Disease: Operative Technique and Nuances: 2-Dimensional Operative Video
Akinduro, Oluwaseun O. , Nottmeier, Eric W.

Mayo Clinic

Operative Neurosurgery | December 14, 2018 | Volume: 17 | Issue: 3 | Pages: E101-E101

10.1093/ons/opy379 | PMID 30551219 Get It

Abstract We describe the operative approach and management for thoracic metastatic disease in a 78-yr-old man with worsening mechanical lower back and left-sided thoracic radicular pain. Imaging of the thoracic spine revealed an osteolytic T11 mass with destruction of the left T11 pedicle and transverse process. Biopsy confirmed spinal metastasis from the liver. Preoperative angiogram was completed for localization of the artery of Adamkewicz and microparticle embolization of the left T11 intercostal artery. Surgical resection was supplemented with electrophysiological monitoring and neuronavigation. The corpectomy was approached by resecting the medial aspect of the rib, transverse process, and pedicle, which were all invaded with tumor. The left T11 nerve root was isolated and sacrificed to allow for placement of the expandable corpectomy cage and also resulted in sustained relief of the patient's radicular pain. The patient recovered from surgery well, with postoperative improvement of his pain. This case highlights the complex technical nuances of this procedure, and the importance of a thorough preoperative evaluation, including angiography, as proper identification of the artery of Adamkewitz can prevent severe neurological deficit from a spinal cord stroke. The patient consented to the procedure.
The current role of clinical flow cytometry in the evaluation of mature B‐cell neoplasms
Seegmiller, Adam C. , Craig, Fiona E. , Craig, Fiona E , Hsi, Eric D.

Mayo Clinic

Cytometry Part B: Clinical Cytometry | December 14, 2018 | Volume: 96 | Issue: 1 | Pages: 20-29

10.1002/cyto.b.21756 | PMID 30549186 Get It

Flow cytometry (FC) has a well‐established role in the diagnostic evaluation of mature B‐cell neoplasms. Effective assessment for lineage associated antigens, aberrant antigen expression, and immunoglobulin light chain restriction requires a well‐designed, optimized, and controlled FC assay. However, it is important for hematopathologists to know when flow cytometry has a more limited role, and other modalities, such as immunohistochemistry, cytogenetic and molecular testing, are more important. This review will discuss the features of an optimal FC assay for the evaluation of mature B‐cell neoplasms, and the current role of FC in the diagnosis and sub‐classification, prognostic assessment, identification of therapeutic targets, and assessment for disease response to therapy. © 2018 International Clinical Cytometry Society
Sonication Culture of Antimicrobial Agent-Containing Cement Spacers Removed during Staged Revisions for Arthroplasty Infection
Gomez-Urena, Eric, Greenwood-Quiantance, Kerryl E., Karau, Melissa J. , Steckelberg, James M., Patel, Robin , Patel, Robin , Sierra, Rafael J.

Mayo Clinic

Journal of Clinical Microbiology | December 11, 2018 | Volume: 57 | Issue: 2 | Pages: No page available

10.1128/jcm.01483-18 | PMID 30541933 Get It

Diagnosis of persistent infection at the time of reimplantation for staged revision of infected arthroplasties is challenging. Implant sonication culture for the diagnosis of prosthetic joint infection (PJI) has improved sensitivity compared to standard periprosthetic tissue culture.
P1253Clinical features and outcomes of patients with chemotherapy-induced Takotsubo stress cardiomyopathy
Liu, V Y, Donisan, Teodora , Agha, Ali , Giza, Dana Elena , Iliescu, Gloria, Kim, P Y, Boone, David L., Herrmann, Joerg , Marmagkiolis, Kostas, Angelini, Paolo , Iliescu, Cezar , Balanescu, Dinu Valentin , Lopez‐Mattei, Juan , Palaskas, Nicolas L , Boone, D L, Yang, Eric H.

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy565.p1253 Get It

P4850Variability in the diagnosis of Brugada syndrome
Plessis, Moira du, Sacher, Frédéric , Béhar, Nathalie , Mabo, P., Ackerman, Michael J. , Schulze‐Bahr, Eric , Gourraud, Jean‐Baptiste , Gourraud, Jean-Baptiste , Belhassen, Bernard , Viskin, Sami , Probst, Vincent

Mayo Clinic

European Heart Journal | December 10, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.p4850 Get It

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202
Dignam, James J., Hamstra, Daniel A. , Lepor, Herbert , Grignon, David J. , Brereton, Harmar D., Zeitzer, Kenneth L. , Venkatesan, Varagur, Horwitz, Eric M. , Pisansky, Thomas M. , Currey, Adam D. , Rosenthal, Seth A. , Sandler, Howard M.

Mayo Clinic

Journal of Clinical Oncology | December 7, 2018 | Volume: 37 | Issue: 3 | Pages: 213-221

10.1200/jco.18.00154 | PMID 30526194 Get It

Background In prostate cancer, end points that reliably portend prognosis and treatment benefit (surrogate end points) can accelerate therapy development. Although surrogate end point candidates have been evaluated in the context of radiotherapy and short-term androgen deprivation (AD), potential surrogates under long-term (24 month) AD, a proven therapy in high-risk localized disease, have not been investigated. Materials and Methods In the NRG/RTOG 9202 randomized trial (N = 1,520) of short-term AD (4 months) versus long-term AD (LTAD; 28 months), the time interval free of biochemical failure (IBF) was evaluated in relation to clinical end points of prostate cancer–specific survival (PCSS) and overall survival (OS). Survival modeling and landmark analysis methods were applied to evaluate LTAD benefit on IBF and clinical end points, association between IBF and clinical end points, and the mediating effect of IBF on LTAD clinical end point benefits. Results LTAD was superior to short-term AD for both biochemical failure (BF) and the clinical end points. Men remaining free of BF for 3 years had relative risk reductions of 39% for OS and 73% for PCSS. Accounting for 3-year IBF status reduced the LTAD OS benefit from 12% (hazard ratio [HR], 0.88; 95% CI, 0.79 to 0.98) to 6% (HR, 0.94; 95% CI, 0.83 to 1.07). For PCSS, the LTAD benefit was reduced from 30% (HR, 0.70; 95% CI, 0.52 to 0.82) to 6% (HR, 0.94; 95% CI, 0.72 to 1.22). Among men with BF, by 3 years, 50% of subsequent deaths were attributed to prostate cancer, compared with 19% among men free of BF through 3 years. Conclusion The IBF satisfied surrogacy criteria and identified the benefit of LTAD on disease-specific survival and OS. The IBF may serve as a valid end point in clinical trials and may also aid in risk monitoring after initial treatment.